Doctors Note Logo

Published on: 10/1/2026

Who should not get the MMR vaccine, and the precautions that apply

People who should avoid or delay the MMR vaccine include those with a severe allergic reaction to a prior dose or its components (such as gelatin or neomycin), anyone who is pregnant or planning pregnancy within one month, and people with weakened immune systems from conditions like HIV, cancer treatment, high-dose steroids, or a family history of immunodeficiency. Precautions also apply if you have a moderate or severe illness, recently received blood products or immune globulin, have a history of low platelets (thrombocytopenia), or had another live vaccine within the past four weeks. Timing, age, and dose spacing matter too, and several of these situations are temporary rather than permanent, so the complete details below are worth reviewing before you decide.

If you are unsure whether a symptom, illness, or medication puts you in one of these groups, a free, instant, online symptom check can help you clarify what is going on in just a few minutes. It asks targeted questions about your health, flags conditions that may affect vaccine timing, and points you toward the right next step, whether that is waiting a few days, calling your clinician, or seeking prompt care.

Last reviewed for medical accuracy: 10/01/2025

answer background

Explanation

MMR Vaccine: Who Should Not Get It and Key Precautions

The MMR vaccine protects against measles, mumps and rubella—three serious, contagious diseases. While it’s safe for most people, there are clear guidelines on MMR vaccine who should not get it precautions. Read on to learn who should skip vaccination and what to consider before and after your shot.


1. Who Should Not Get the MMR Vaccine (Contraindications)

The following groups should not receive the MMR vaccine. If you fall into any of these categories, talk to your doctor about alternative protection strategies.

  • Severe allergic reaction to a prior dose
    • Anaphylaxis (life-threatening allergy) after a previous MMR shot.

  • Known allergy to vaccine components
    • Gelatin (used as a stabilizer)
    • Neomycin (an antibiotic used in the vaccine)
    • Any other ingredient listed on the vaccine label

  • Pregnancy
    • Live vaccines can theoretically affect an unborn baby.
    • Women should avoid becoming pregnant for at least 4 weeks after MMR.

  • Significant immunosuppression
    • Cancer treatment (chemotherapy, radiation)
    • Primary immunodeficiency disorders (e.g., severe combined immunodeficiency)
    • High-dose steroids (e.g., ≥2 mg/kg/day of prednisone for ≥2 weeks)
    • Biologic immunosuppressive therapies (e.g., certain monoclonal antibodies)
    • Advanced HIV infection (CD4 count <200 cells/mm³)

  • Recent blood products or antibody treatments
    • Immune globulin therapy in the past 3–11 months (timing varies by dose)
    • Whole blood or plasma transfusion in the past 3–11 months

  • History of thrombocytopenia or thrombocytopenic purpura
    • Low platelet count after a previous MMR dose
    • This is rare but requires expert evaluation


2. Precautions Before Getting the MMR Vaccine

Even if you aren’t in a strict contraindication category, certain factors may warrant a delay or extra monitoring.

  • Moderate or severe acute illness
    • Fever, severe diarrhea, vomiting or dehydration
    • Postpone until recovery to avoid confusing illness symptoms with vaccine side effects

  • Recent or planned tuberculin skin test
    • MMR can cause a false-negative TB skin test for 4–6 weeks
    • Consider doing the skin test first or waiting after vaccination

  • Family or household member severely immunocompromised
    • Although transmission risk is extremely low, some experts recommend caution
    • In most cases, the benefit of vaccination outweighs theoretical risks

  • History of seizures or neurologic conditions
    • Febrile seizures can occur rarely (1 in 3,000–4,000 doses)
    • If there’s a history of seizures, discuss risks and benefits

  • Uncontrolled HIV infection or borderline immune status
    • Even mild immunosuppression may affect vaccine response
    • Consult an infectious-disease specialist if CD4 count is near threshold


3. Key Precautions for Special Situations

  1. Pregnancy Planning

    • Delay pregnancy for at least 4 weeks after MMR.
    • Verify non-pregnant status with a test if there’s any doubt.
  2. Breastfeeding

    • MMR is considered safe in breastfeeding mothers.
    • Infant side effects from breast milk exposure are not a concern.
  3. Travelers to High-Risk Areas

    • Check measles, mumps or rubella outbreaks before travel.
    • If you’re unsure about your vaccination history, a booster may be recommended.
  4. Healthcare Workers and Students

    • Proof of immunity or vaccination is often required.
    • Titer testing (blood test for antibodies) can confirm immune status.
  5. Outbreak Settings

    • In a community outbreak, public health officials may recommend MMR even in some precaution groups—consult local guidelines.

4. After the MMR Vaccine: Monitoring and When to Seek Help

Most side effects are mild and clear up in a few days. Still, it’s smart to know what to watch for:

Common, Mild Reactions

  • Low-grade fever (up to 2 weeks post-vaccine)
  • Rash (appears 7–12 days later)
  • Soreness or redness at the injection site

Uncommon, Moderate Reactions

  • Joint pain (more common in adult women)
  • Swollen glands in neck or underarms
  • Temporary low platelet count

Rare, Serious Reactions

  • High fever (>105°F)
  • Seizures (usually febrile)
  • Severe rash or difficulty breathing (sign of anaphylaxis)

If you experience any of these serious symptoms, seek medical care immediately.


5. Tips to Minimize Side Effects

  • Stay hydrated before and after vaccination.
  • Use acetaminophen (paracetamol) for fever or discomfort—follow dosage instructions.
  • Apply a cool compress to the injection site for soreness.
  • Rest and monitor symptoms for up to two weeks.

6. Free Symptom Checker

If you’re unsure whether a symptom after MMR is normal or needs attention, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a convenient way to get guidance and know when to seek care.

Free, online symptom check, using the doctor approved Ubie Symptom Checker


7. Final Recommendations

  • Review your medical history and current health status with a healthcare provider—especially if any contraindications or precautions apply.
  • Keep a copy of your vaccination record and share it with new healthcare providers or schools when needed.
  • Stay informed about outbreak alerts in your community or travel destination.
  • Report any serious side effects to your doctor or local health department.

Speak to a doctor about any life-threatening or serious issues related to the MMR vaccine or any other health concerns. Your healthcare provider will help you weigh the benefits and risks based on credible, up-to-date guidance.

(References)

  • * Freed GL, Katz SL, Clark SJ. Safety of vaccinations. Miss America, the media, and public health. JAMA. 1996 Dec 18;276(23):1869-72. doi: 10.1001/jama.276.23.1869. PMID: 8968002.

  • * Conway SP. Opportunistic immunisation in hospital. Arch Dis Child. 1999 Nov;81(5):422-5. doi: 10.1136/adc.81.5.422. PMID: 10519717; PMCID: PMC1718117.

  • * Hull B, McIntyre P. Mapping immunisation coverage and conscientious objectors to immunisation in NSW. N S W Public Health Bull. 2003 Jan-Feb;14(1-2):8-12. doi: 10.1071/nb03003. PMID: 12732911.

  • * Hügle B, Suchowerskyj P, Schuster V. [Varicella vaccination: who should be vaccinated these days?]. MMW Fortschr Med. 2005 Feb 24;147(8):31-2, 34-5. PMID: 18441563.

  • * Elliman DA, Bedford HE. Refer children with a previous serious reaction to an expert. BMJ. 2011 Sep 13;343:d5779; author reply d5783. doi: 10.1136/bmj.d5779. Epub 2011 Sep 13. PMID: 21914743.

  • * Soon IS, deBruyn JC, Wrobel I. Immunization history of children with inflammatory bowel disease. Can J Gastroenterol. 2013 Apr;27(4):213-6. doi: 10.1155/2013/539524. PMID: 23616959; PMCID: PMC3742478.

  • * Mumps outbreak. Med Lett Drugs Ther. 2014 Mar 17;56(1438):21. PMID: 24662158.

  • * Akikusa JD, Crawford NW. Vaccination in paediatric rheumatology. Curr Rheumatol Rep. 2014 Aug;16(8):432. doi: 10.1007/s11926-014-0432-9. PMID: 24925588.

  • * Lee AM, Burns JC, Tremoulet AH. Safety of Infliximab Following Live Virus Vaccination in Kawasaki Disease Patients. Pediatr Infect Dis J. 2017 Apr;36(4):435-437. doi: 10.1097/INF.0000000000001447. PMID: 27918378.

  • * Andrews N, Stowe J, Hani E, Jeffery-Smith A, Ramsay M. The risk of idiopathic thrombocytopenic purpura after first and second measles, mumps, rubella (MMR) vaccine doses in children born in England 2000-2019. Vaccine. 2026 Oct 24;92:129168. doi: 10.1016/j.vaccine.2026.129168. Epub 2026 Sep 22. PMID: 42771940.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.